ストックスクリーナーアプリを入手
5.23
0.19%
-0.08
前日終値:
$5.31
開ける：
$5.35
24時間の取引高:
10,884
Relative Volume:
0.22
時価総額：
$8.03M
収益：
$57.92M
当期純損益:
$-31.14M
株価収益率:
-0.9402
EPS:
-5.5628
ネットキャッシュフロー:
$-19.56M
1週間 パフォーマンス:
-3.81%
1か月 パフォーマンス:
+7.83%
6か月 パフォーマンス:
-50.26%
1年 パフォーマンス:
-84.98%
1日の値動き範囲:
$5.07
$5.4725
1週間の範囲:
$5.0501
$5.65
52週間の値動き範囲:
$2.5211
$61.00
Dna X Inc Stock (SONM) Company Profile
Compare SONM vs MSFT, ORCL, PLTR, CRWD, SNPS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
5.3979 | 7.90M | 57.92M | -31.14M | -19.56M | -5.5628 |
|
MSFT
Microsoft Corporation
|
406.07 | 3.00T | 305.45B | 119.26B | 77.41B | 15.98 |
|
ORCL
Oracle Corp
|
152.79 | 428.27B | 61.02B | 15.61B | -13.18B | 5.3211 |
|
PLTR
Palantir Technologies Inc
|
152.70 | 352.10B | 4.48B | 1.63B | 2.10B | 0.6328 |
|
CRWD
Crowdstrike Holdings Inc
|
395.82 | 98.68B | 4.57B | -315.36M | 1.10B | -1.2634 |
|
SNPS
Synopsys Inc
|
429.99 | 81.28B | 8.00B | 1.10B | 2.28B | 6.4708 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2019-10-31 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2019-07-18 | 開始されました | B. Riley FBR | Buy |
| 2019-07-09 | アップグレード | National Securities | Neutral → Buy |
| 2019-06-10 | 開始されました | National Securities | Neutral |
| 2019-06-04 | 開始されました | Lake Street | Buy |
| 2019-06-04 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Dna X Inc (SONM) 最新ニュース
SONM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
DNA X (NASDAQ: SONM) revises view of DNA X LLC acquisition - Stock Titan
DNA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
How DNA's Double Helix Structure Was Discovered - Britannica
SONM SEC FilingsDNA X 10-K, 10-Q, 8-K Forms - Stock Titan
Acurx Pharmaceuticals (ACXP) Secures New US Patent for DNA Polymerase IIIC Inhibitors - Yahoo Finance Singapore
Major SONM holder DNA Holdings Venture reports 223,201 shares - Stock Titan
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation - Stock Titan
1 Main Capital exits Sonim Technologies (SONM) with 0.0% ownership - Stock Titan
Leadership and Strategy Shift at DNA X Following Core Business Divestment - AD HOC NEWS
Sonim Technologies Names Mike Mulica Acting Chief Executive - TipRanks
DNA X, Inc. Appoints Mike Mulica as Acting Chief Executive Officer, Effective February 9, 2026 - marketscreener.com
DNAX stock jumps to $0.0001 on 09 Feb 2026 (PNK): liquidity and valuation in focus - Meyka
Nancy Guthrie’s blood was found on her porch, DNA testing confirms - WBAY
Sonim Technologies Sees Executive Departures and New Board Appointment - TipRanks
Leadership shake-up at DNA X (NASDAQ: SONM) as CEO exits and investor designee joins board - Stock Titan
Acurx patent backs new antibiotics for C. diff and MRSA - Stock Titan
Will Sonim Technologies Inc. stock outperform value stocksJuly 2025 Opening Moves & Weekly Stock Breakout Alerts - mfd.ru
Best Tech Penny Stocks Right Now • Updated Daily - Benzinga
Sonim Technologies Public Entity Rebrands As DNA X, Inc., A Digital Asset Management Company - IT Business Net
Five reasons to go rugged in public safety: Sonim Technologies on building phones for fireground realties - International Fire & Safety Journal
Sonim Technologies rebrands as DNA X following asset sale to NEXA - Investing.com Nigeria
Sonim Technologies Rebrands as DNA X, Shifts Strategy - TipRanks
DNA X Signs Asset Purchase Agreement Amendment and Terminates Streeterville Notes - TradingView
Sonim sells assets, rebrands as DNA X running digital asset platform - stocktitan.net
EPS Watch: Is Sonim Technologies Inc exposed to currency risksMarket Trend Review & Entry Point Confirmation Signals - baoquankhu1.vn
Market Wrap: Is Sonim Technologies Inc affected by consumer sentimentWeekly Stock Summary & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Sonim Technologies : NEXA Completes Acquisition of Sonim - marketscreener.com
Sonim Technologies : News Release - marketscreener.com
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Drops Despite Market Gains: Important Facts to Note - Nasdaq
Sonim Technologies (SONM) Projected to Post Earnings on Friday - Defense World
Volatility Watch: Should value investors consider Sonim Technologies IncWeekly Trade Report & Risk Managed Investment Entry Signals - baoquankhu1.vn
Sentiment Review: What is the Moat Score of Sonim Technologies IncJuly 2025 Snapshot & Weekly Setup with High ROI Potential - baoquankhu1.vn
Portfolio Recap: What are the risks of holding Sonim Technologies IncJuly 2025 Trade Ideas & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Whats the fair value of Sonim Technologies Inc stockTrade Exit Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Resistance Check: Will Sonim Technologies Inc benefit from seasonalityWeekly Trade Summary & Weekly Chart Analysis and Guides - baoquankhu1.vn
Integrated DNA Technologies Expands Synthetic Biology Portfolio with Ansa Biotechnologies’ Clonal DNA and XL Clonal DNA Products - Business Wire
Quarterly Trades: Is Sonim Technologies Inc affected by consumer sentimentWeekly Trend Recap & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Inflation Data: Can Sonim Technologies Inc stock hit analyst price targets2025 Key Highlights & Reliable Intraday Trade Plans - Bộ Nội Vụ
Options Flow: Will Sonim Technologies Inc stock outperform tech sector in 2025Stop Loss & Low Risk Growth Stock Ideas - Bộ Nội Vụ
Inflation Data: Will Sonim Technologies Inc. stock outperform tech sector in 2025Treasury Yields & Daily Entry Point Trade Alerts - Bộ Nội Vụ
VIX Spike: Why Sonim Technologies Inc. stock is favored by top institutionsProfit Target & Daily Volume Surge Trade Alerts - Bộ Nội Vụ
Is Sonim Technologies Inc. (6RO) stock overpriced at current multiplesChart Signals & Low Drawdown Trading Strategies - ulpravda.ru
Loss Report: How Sonim Technologies Inc stock performs in weak economyWeekly Stock Recap & Daily Entry Point Trade Alerts - Bộ Nội Vụ
Will Sonim Technologies Inc. (2W9) stock boost dividends further2025 Investor Takeaways & High Yield Stock Recommendations - Улправда
Can Sonim Technologies Inc. stock maintain growth trajectoryEarnings Overview Summary & Accurate Buy Signal Alerts - Улправда
Market Recap: How rising interest rates impact Sonim Technologies Inc. stock2025 Market WrapUp & AI Powered Buy and Sell Recommendations - Улправда
How rising interest rates impact Sonim Technologies Inc. stockQuarterly Portfolio Summary & Precise Trade Entry Recommendations - Улправда
How Sonim Technologies Inc. stock valuations compare to rivalsMomentum Trading Signals & Market Trend Real-Time Reports - ulpravda.ru
The Truth About Myriad Genetics Inc: Is This DNA Stock a Sleeper Goldmine or Just Overhyped? - AD HOC NEWS
Sonim stockholders approve sale of rugged device business to NEXA By Investing.com - Investing.com Australia
Dna X Inc (SONM) 財務データ
収益
当期純利益
現金流量
EPS
Dna X Inc (SONM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| LYTTON LAURENCE W | 10% Owner |
Jun 30 '25 |
Sale |
1.39 |
400,514 |
556,714 |
0 |
| Becher Charles | See Remarks |
Apr 23 '25 |
Sale |
1.45 |
31,326 |
45,423 |
62,668 |
| MULICA MICHAEL C | Director |
Apr 23 '25 |
Sale |
1.45 |
27,818 |
40,336 |
73,292 |
| Crolius Clayton | Chief Financial Officer |
Apr 23 '25 |
Sale |
1.45 |
11,634 |
16,869 |
30,958 |
| Cassano James S | Director |
Apr 23 '25 |
Sale |
1.45 |
23,381 |
33,902 |
49,126 |
| Wang Jeffrey | Director |
Apr 23 '25 |
Sale |
1.45 |
4,478 |
6,493 |
21,301 |
| Steenstra Jack | Director |
Apr 23 '25 |
Sale |
1.45 |
23,381 |
33,902 |
49,139 |
0.74%
大文字化:
|
ボリューム (24 時間):